Sustained CD4 responses after virological failure of protease inhibitor-containing therapy

被引：0

作者：

Deeks, SG ^{[1
]}

Grant, RM

机构：

[1] Univ Calif San Francisco, San Francisco, CA 94143 USA

[2] San Francisco Gen Hosp, San Francisco, CA 94110 USA

[3] Gladstone Inst Virol & Immunol, San Francisco, CA USA

来源：

ANTIVIRAL THERAPY | 1999年 / 4卷

关键词：

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

This article explores current controversies related to 'discordant' responses to antiviral therapy, that is to say, patients with a sustained CD4 cell response despite virological failure. Observational clinical data of patients receiving protease inhibitor-based therapy who had a sustained CD4 cell count even with incomplete viral suppression will be presented, as well as possible mechanisms and clinical implications.

引用

页码：7 / 11

页数：5

共 50 条

[1] Changes in CD4 lymphocyte counts after interruption of therapy in patients with viral failure on protease inhibitor-containing regimens
Youle, M
Janossy, G
Turnbull, W
Tilling, R
Loveday, C
Mocroft, A
Tyrer, M
Madge, S
Wilson, D
Dykhoff, A
Johnson, M
Phillips, AN
AIDS, 2000, 14 (12) : 1717 - 1720
[2] Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimen
Renaud, M
Katlama, C
Mallet, A
Calvez, V
Carcelain, G
Tubiana, R
Jouan, M
Caumes, E
Agut, H
Bricaire, F
Debré, P
Autran, B
AIDS, 1999, 13 (06) : 669 - 676
[3] Efficacy of salvage therapy containing ritonavir and saquinavir after failure of single protease inhibitor-containing regimens
Hall, CS
Raines, CP
Barnett, SH
Moore, RD
Gallant, JE
AIDS, 1999, 13 (10) : 1207 - 1212
[4] The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral load
Miller, V
Sabin, CA
Phillips, AN
Rottmann, C
Rabenau, H
Weidmann, E
Rickerts, V
Findhammer, S
Helm, EB
Staszewski, S
AIDS, 2000, 14 (14) : 2129 - 2136
[5] Detection of resistance mutations and CD4 slopes in individuals experiencing sustained virological failure
Schultze, Anna
Paredes, Roger
Sabin, Caroline
Phillips, Andrew N.
Pillay, Deenan
Kirk, Ole
Lundgren, Jens D.
Pozniak, Anton
Pozniak, Anton
Nelson, Mark
Cozzi-Lepri, Alessandro
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 152 - 152
[6] Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen
Le Moing, V
Chêne, G
Carrieri, MP
Alioum, A
Brun-Vézinet, F
Piroth, L
Cassuto, JP
Moatti, JP
Raffi, F
Leport, C
AIDS, 2002, 16 (01) : 21 - 29
[7] Kinetics of CD4 cells after discontinuation of antiretroviral therapy in patients with virological failure and a CD4 cell count greater than 500 cells/μl
Mussini, C
Bugarini, R
Perno, CF
Antinori, A
Borghi, V
Bertoli, A
D'Arrigo, R
Bedini, A
Mongiardo, N
Cossarizza, A
Esposito, R
AIDS, 2002, 16 (11) : 1551 - 1554
[8] Accuracy of WHO CD4 cell count criteria for virological failure of antiretroviral therapy
Keiser, Olivia
MacPhail, Patrick
Boulle, Andrew
Wood, Robin
Schechter, Mauro
Dabis, Francois
Sprinz, Eduardo
Egger, Matthias
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2009, 14 (10) : 1220 - 1225
[9] CD4 Responses in the Setting or Suboptimal Virological Responses to Antiretroviral Therapy: Features, Outcomes, and Associated Factors
Collazos, Julio
Asensi, Victor
Antonio Carton, Jose
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2009, 25 (07) : 647 - 655
[10] The Danish protease inhibitor study: A randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection
Katzenstein, TL
Kirk, O
Pedersen, C
Lundgren, JD
Nielsen, H
Obel, N
Nielsen, C
Mathiesen, LR
Gerstoft, J
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (03): : 744 - 750

← 1 2 3 4 5 →